ANI Pharmaceuticals | ANIP - أصول متداولة





أصول متداولة تغيير تاريخ
AbbVie USD 37.48B 3.81B 2026-09
ANI Pharmaceuticals USD 902.82M 77.39M 2026-09
Aurora Cannabis CAD 393.45M 4M 2026-06
Canopy Growth CAD 506.36M 23.1M 2026-06
Eli Lilly USD 65.26B 591M 2026-09
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Heron Therapeutics USD 209.11M 20.73M 2026-09
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Novartis USD 28.75B 2.14B 2026-09
Omeros USD 69.65M 26.53M 2025-06
Perrigo USD 2.4B 49.7M 2026-09
Sun Pharmaceuticals INR 692.67B 54.06B 2026-09
Teva Pharmaceutical Industries USD 14.6B 842M 2026-09